WAM
TGTX icon

Weiss Asset Management’s TG Therapeutics TGTX Stock Holding History

Weiss Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
+375,082
New +$15.4M 0.22% 77
2025
Q2 		– Sell
-19,851
Closed -$783K – 524
2025
Q1 		$783K Buy
+19,851
New +$668K 0.02% 207

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Weiss Asset Management's TGTX Position: Q2 2026 in Review

Weiss Asset Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 375,082 shares worth $20.6M. The stake represents 0.22% of the portfolio and ranks #77 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in TGTX as recently as Q1 2025.

Weiss Asset Management first reported a position in TGTX in Q1 2025 and has held it in 2 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Weiss Asset Management held 375,082 shares of TG Therapeutics worth $20.6M as of Q2 2026.
  • TG Therapeutics was a new Weiss Asset Management position in Q2 2026.
  • TG Therapeutics made up 0.22% of Weiss Asset Management's portfolio in Q2 2026, its #77 holding.
  • Weiss Asset Management first reported a position in TG Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.